Diploma (LON:DPLM) Shares Cross Above Two Hundred Day Moving Average of $3,316.85

Shares of Diploma PLC (LON:DPLM) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 3,316.85 ($40.97) and traded as high as GBX 3,594 ($44.39). Diploma shares last traded at GBX 3,542 ($43.75), with a volume of 163,216 shares trading hands.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the stock. Shore Capital reissued a “buy” rating on shares of Diploma in a research note on Wednesday, March 27th. Berenberg Bank lifted their price target on shares of Diploma from GBX 3,800 ($46.94) to GBX 4,400 ($54.35) and gave the stock a “buy” rating in a research note on Thursday, March 28th.

Diploma Price Performance

The stock has a market cap of £4.77 billion, a PE ratio of 3,935.56, a P/E/G ratio of 2.82 and a beta of 0.73. The company has a current ratio of 2.06, a quick ratio of 0.80 and a debt-to-equity ratio of 44.05. The company’s 50 day moving average is GBX 3,480.20 and its 200-day moving average is GBX 3,316.85.

Diploma Increases Dividend

The business also recently disclosed a dividend, which was paid on Friday, February 2nd. Shareholders of record on Thursday, January 18th were issued a dividend of GBX 40 ($0.49) per share. This is a positive change from Diploma’s previous dividend of $16.50. This represents a yield of 1.32%. The ex-dividend date was Thursday, January 18th. Diploma’s dividend payout ratio (DPR) is currently 6,333.33%.

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.